Qayyim Said

1.1k total citations
40 papers, 816 citations indexed

About

Qayyim Said is a scholar working on Hematology, Endocrinology, Diabetes and Metabolism and Physiology. According to data from OpenAlex, Qayyim Said has authored 40 papers receiving a total of 816 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 11 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Physiology. Recurrent topics in Qayyim Said's work include Tuberous Sclerosis Complex Research (7 papers), Platelet Disorders and Treatments (6 papers) and Blood groups and transfusion (6 papers). Qayyim Said is often cited by papers focused on Tuberous Sclerosis Complex Research (7 papers), Platelet Disorders and Treatments (6 papers) and Blood groups and transfusion (6 papers). Qayyim Said collaborates with scholars based in United States, United Kingdom and Mexico. Qayyim Said's co-authors include Gary M. Oderda, Kenneth C. Jackson, Dale Rublee, R. Scott Evans, Jim Lloyd, Matthew H. Samore, Gregory J. Stoddard, Diana Brixner, Bradley C. Martin and Reid D. Landes and has published in prestigious journals such as Blood, Journal of Adolescent Health and Journal of the Neurological Sciences.

In The Last Decade

Qayyim Said

39 papers receiving 780 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qayyim Said United States 14 268 172 161 140 129 40 816
Winghan Jacqueline Kwong United States 21 171 0.6× 109 0.6× 534 3.3× 123 0.9× 91 0.7× 70 1.4k
Sumitra Balasubramanian United States 14 266 1.0× 47 0.3× 188 1.2× 83 0.6× 227 1.8× 15 1.2k
Ulf E. Kongsgaard Norway 21 485 1.8× 396 2.3× 131 0.8× 132 0.9× 23 0.2× 79 1.2k
Nadya Kagansky Israel 11 142 0.5× 30 0.2× 208 1.3× 294 2.1× 284 2.2× 24 1.2k
Tess E Cooper Australia 17 166 0.6× 140 0.8× 29 0.2× 192 1.4× 23 0.2× 41 945
Andrew T. McAfee United States 14 153 0.6× 33 0.2× 107 0.7× 36 0.3× 140 1.1× 30 637
Dylan M. Zylla United States 15 145 0.5× 134 0.8× 62 0.4× 46 0.3× 29 0.2× 34 806
Pia Søe Jensen Denmark 14 678 2.5× 37 0.2× 461 2.9× 174 1.2× 51 0.4× 37 1.1k
T C Chalmers United States 11 165 0.6× 146 0.8× 91 0.6× 184 1.3× 39 0.3× 19 643
Minna Löppönen Finland 16 137 0.5× 20 0.1× 104 0.6× 192 1.4× 88 0.7× 34 937

Countries citing papers authored by Qayyim Said

Since Specialization
Citations

This map shows the geographic impact of Qayyim Said's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qayyim Said with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qayyim Said more than expected).

Fields of papers citing papers by Qayyim Said

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qayyim Said. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qayyim Said. The network helps show where Qayyim Said may publish in the future.

Co-authorship network of co-authors of Qayyim Said

This figure shows the co-authorship network connecting the top 25 collaborators of Qayyim Said. A scholar is included among the top collaborators of Qayyim Said based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qayyim Said. Qayyim Said is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lal, Lincy S., et al.. (2020). Second‐line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records. Research and Practice in Thrombosis and Haemostasis. 4(7). 1131–1140. 11 indexed citations
2.
Tremblay, Gabriel, Qayyim Said, Anuja Roy, et al.. (2019). <p>Budget Impact Of Eltrombopag As First-Line Treatment For Severe Aplastic Anemia In The United States</p>. ClinicoEconomics and Outcomes Research. Volume 11. 673–681. 6 indexed citations
3.
Rentz, Anne M., Anne Skalicky, Zhimei Liu, et al.. (2018). Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. Journal of Patient-Reported Outcomes. 2(1). 30–30. 3 indexed citations
4.
Song, Jinlin, Elyse Swallow, Qayyim Said, et al.. (2018). Epilepsy treatment patterns among patients with tuberous sclerosis complex. Journal of the Neurological Sciences. 391. 104–108. 21 indexed citations
5.
Said, Qayyim, et al.. (2018). Evaluation of Treatment Outcomes after Second-Line Treatment Among Adult Patients with Immune Thrombocytopenia. Blood. 132(Supplement 1). 3765–3765. 1 indexed citations
6.
Tremblay, Gabriel, et al.. (2018). Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia. ClinicoEconomics and Outcomes Research. Volume 10. 705–713. 8 indexed citations
7.
Tremblay, Gabriel, Menaka Bhor, Qayyim Said, et al.. (2018). Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia. ClinicoEconomics and Outcomes Research. Volume 10. 715–721. 7 indexed citations
8.
Carmichael, John D., Michael S. Broder, Dasha Cherepanov, et al.. (2017). Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center. BMC Endocrine Disorders. 17(1). 49–49. 9 indexed citations
9.
Geer, Eliza B., Alejandro Ayala, Vivien Bonert, et al.. (2017). Follow-up intervals in patients with Cushing’s disease: recommendations from a panel of experienced pituitary clinicians. Pituitary. 20(4). 422–429. 7 indexed citations
10.
Song, Xue, Zhimei Liu, Katherine Cappell, et al.. (2016). Healthcare utilization and costs in patients with tuberous sclerosiscomplex-related renal angiomyolipoma. Journal of Medical Economics. 20(4). 388–394. 5 indexed citations
11.
Faramawi, Mohammed F., et al.. (2016). High-normal blood pressure is associated with visit-to-visit blood pressure variability in the US adults. Blood Pressure. 26(1). 18–23. 2 indexed citations
12.
Said, Qayyim, et al.. (2014). Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured Population. Clinical Journal of Pain. 31(5). 414–424. 32 indexed citations
13.
Faramawi, Mohammed F., et al.. (2014). Metabolic syndrome is associated with visit-to-visit systolic blood pressure variability in the US adults. Hypertension Research. 37(9). 875–879. 19 indexed citations
14.
Dhamane, Amol D., Bradley C. Martin, Diana Brixner, Teresa J. Hudson, & Qayyim Said. (2013). Metabolic Monitoring of Patients Prescribed Second-Generation Antipsychotics. Journal of Psychiatric Practice. 19(5). 360–374. 12 indexed citations
15.
Ghate, Sameer R., Christina A. Porucznik, Qayyim Said, et al.. (2013). Association Between Second-Generation Antipsychotics and Changes in Body Mass Index in Adolescents. Journal of Adolescent Health. 52(3). 336–343. 13 indexed citations
16.
Said, Qayyim, Bradley C. Martin, Vijay N. Joish, C. Kreilick, & Stephen C. Mathai. (2012). The cost to managed care of managing pulmonary hypertension. Journal of Medical Economics. 15(3). 500–508. 37 indexed citations
17.
Brixner, Diana, Sameer R. Ghate, Carrie McAdam‐Marx, Rami Ben‐Joseph, & Qayyim Said. (2008). Association Between Cardiometabolic Risk Factors and Body Mass Index Based on Diagnosis and Treatment Codes in an Electronic Medical Record Database. Journal of Managed Care Pharmacy. 14(8). 756–767. 8 indexed citations
18.
Said, Qayyim, et al.. (2008). Somnolence effects of antipsychotic medications and the risk of unintentional injury. Pharmacoepidemiology and Drug Safety. 17(4). 354–364. 7 indexed citations
19.
Oderda, Gary M., Qayyim Said, R. Scott Evans, et al.. (2007). Opioid-Related Adverse Drug Events in Surgical Hospitalizations: Impact on Costs and Length of Stay. Annals of Pharmacotherapy. 41(3). 400–407. 280 indexed citations
20.
Jackson, Kenneth C., et al.. (2007). An Employer-Based Cost-Benefit Analysis of a Novel Pharmacotherapy Agent for Smoking Cessation. Journal of Occupational and Environmental Medicine. 49(4). 453–460. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Winghan Jacqueline Kwong Breakdown of academic impact, for papers by Sumitra Balasubramanian Breakdown of academic impact, for papers by Ulf E. Kongsgaard Breakdown of academic impact, for papers by Nadya Kagansky Breakdown of academic impact, for papers by Tess E Cooper Breakdown of academic impact, for papers by Andrew T. McAfee Breakdown of academic impact, for papers by Dylan M. Zylla Breakdown of academic impact, for papers by Pia Søe Jensen Breakdown of academic impact, for papers by T C Chalmers Breakdown of academic impact, for papers by Minna Löppönen
Rankless by CCL
2026